Cargando…
Targeting viruses in their phase
The pathogenicity of SARS-CoV-2 and respiratory syncytial virus (RSV) involves mechanisms of liquid–liquid phase separation, which can be explored as targets for new antiviral therapeutics.
Autor principal: | Strzyz, Paulina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278171/ https://www.ncbi.nlm.nih.gov/pubmed/34262155 http://dx.doi.org/10.1038/s41580-021-00400-7 |
Ejemplares similares
-
WNK1, a molecular crowding sensor, links phase separation to cellular physiological stress
por: Lan, Tinghui, et al.
Publicado: (2023) -
Bacteria, archae, fungi and viruses: it takes a community to eliminate waste
por: Siles, José Angel, et al.
Publicado: (2019) -
Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023) -
Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015) -
Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022)